FDA Approved: MOTEGRITY — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved MOTEGRITY for chronic idiopathic constipation in adults in an original NDA from Takeda Pharmaceuticals America, Inc. (prucalopride).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• MOTEGRITY (Prucalopride)

Snippet

ORIG AP for MOTEGRITY (PRUCALOPRIDE)